Back to Feed
Fintech– 0
Eli Lilly's New Oral Weight Loss Drug Clears Cardiovascular Bar
Benzinga·
Eli Lilly Foundayo shows cardiovascular safety and stronger A1C, weight reduction, while the FDA flags liver risk, seeks additional data..
Original Source
Benzinga — www.benzinga.comRelated in Fintech
X Money Tests Whether Social Commerce Can Hold Consumer Deposits
PYMNTSBeaten-down digital asset treasury names lead crypto stock surge as bitcoin hits
CoinDeskBitcoin retakes $78,000 as Trump declares Hormuz ‘open and ready for business’
The BlockSen. Blumenthal presses DOJ and Treasury on Binance monitor amid Iran sanctions
The Block